Showing results (1291-1300 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|September 26, 2014
Current and investigational drugs for the prevention of migraine in adults and childrenFrederick G Freitag, Derrick ShumateCNS Drugs|December 18, 2014
The impact of medication on health-related quality of life in patients with generalized anxiety disorderHilary Wilson, Sally Mannix, Hafiz Oko-osi, et al.CNS Drugs|October 25, 2017
Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord InjuryMirHojjat Khorasanizadeh, Mahsa Eskian, Alexander R Vaccaro, et al.CNS Drugs|October 6, 2017
Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity DisorderJeffrey H Newcorn, Peter Nagy, Ann C Childress, et al.CNS Drugs|September 16, 2015
Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical AspectsGail D Anderson, Russell P SanetoCNS Drugs|September 16, 2015
Diagnosis, Epidemiology and Management of Mixed States in Bipolar DisorderAndrea Fagiolini, Anna Coluccia, Giuseppe Maina, et al.CNS Drugs|August 6, 2015
Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysisMarlene Bloechliger, Stephan Rüegg, Susan S Jick, et al.CNS Drugs|July 11, 2016
Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-AnalysisChiara Bernagie, Marina Danckaerts, Martien Wampers, et al.CNS Drugs|July 13, 2016
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label ExtensionWolfgang H Oertel, Yngve Hallström, Gerda M Saletu-Zyhlarz, et al.Pageof 211